ROYAL BANK OF CANADA - MINK THERAPEUTICS INC ownership

MINK THERAPEUTICS INC's ticker is and the CUSIP is 603693102. A total of 37 filers reported holding MINK THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MINK THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$0160
+29.0%
0.00%
Q1 2024$0
-100.0%
124
-81.0%
0.00%
Q4 2023$1,0000.0%651
+0.3%
0.00%
Q3 2023$1,0000.0%649
+20.6%
0.00%
Q2 2023$1,000538
+393.6%
0.00%
Q1 2023$0
-100.0%
109
-52.0%
0.00%
Q4 2022$1,0000.0%227
-51.5%
0.00%
Q3 2022$1,000468
+277.4%
0.00%
Q1 2022$0
-100.0%
124
-74.4%
0.00%
Q4 2021$2,0004850.00%
Other shareholders
MINK THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Longbow Finance SA 166,666$158,1990.02%
Covestor Ltd 1,055$10.00%
Qube Research & Technologies Ltd 1,941$1,8420.00%
CHILTON CAPITAL MANAGEMENT LLC 309$2940.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 1,548$1,4690.00%
Allworth Financial LP 2$20.00%
Camelot Portfolios, LLC 205$1950.00%
BANK OF AMERICA CORP /DE/ 2,038$1,9340.00%
WELLS FARGO & COMPANY/MN 10,860$10,3080.00%
NORTHERN TRUST CORP 11,073$10,5110.00%
View complete list of MINK THERAPEUTICS INC shareholders